BSEM
BioStem Technologies, Inc.
There isn't enough reported data to score BSEM yet.
BSEM Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Unavailable | |
| Strong |
BSEM's balance sheet is currently strong, but its revenue and profitability are under pressure. There isn't enough data to rate its cash flow.
BSEM PE Valuation
BSEM has no meaningful PE right now: it lost money over the past year.
BSEM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect BSEM's losses to grow, with revenue declining.
BSEM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.35 | -387% |
| Q2 2026 | -$1.68 | -251% |
| Q1 2026 | -$1.18 | -183% |
| Q4 2025 | -$0.49 | -134% |
| Q3 2025 | $0.82 | +34% |
| Q2 2025 | $1.11 | +247% |
| Q1 2025 | $1.43 | +$1.63 |
| Q4 2024 | $1.43 | +$1.94 |
BSEM has swung to a loss: it lost $2.35 per share over the past year, after a profit the year before.
BSEM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.6M | -27% |
| Q2 2026 | $7.9M | -84% |
| Q1 2026 | $6.1M | -92% |
| Q3 2025 | $10.5M | -87% |
| Q2 2025 | $49.3M | -34% |
| Q1 2025 | $72.5M | +73% |
| Q4 2024 | $102.9M | +799% |
| Q3 2024 | $82.6M | +2194% |
BSEM's revenue has slid since its 2024 peak: $8M last quarter, down 27% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -128% | -142 points |
| Q2 2026 | -106% | -107 points |
| Q1 2026 | -145% | -152 points |
| Q3 2025 | 14% | +2.6 points |
| Q2 2025 | 0.2% | -12 points |
| Q1 2025 | 7.2% | -3.8 points |
| Q4 2024 | 8.2% | +33 points |
| Q3 2024 | 11% | -3.5 points |
BSEM's operating margin was −128% last quarter, down 128 points from the same quarter a year ago.
BSEM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.8M | -$4M |
| Q1 2026 | -$827.3K | -121% |
| Q4 2025 | $2.4M | -70% |
| Q3 2025 | -$4.8M | -152% |
| Q2 2025 | $5.1M | -18% |
| Q1 2025 | $3.9M | +622% |
| Q4 2024 | $8M | +$9.4M |
| Q3 2024 | $9.3M | +$9.8M |
BSEM's free cash flow was −$12M over the past year, against $26M the year before.
BSEM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.1% | +537K shares |
| 1 year | -23% | -5.4M shares |
| 3 years | +32% | +4.4M shares |
| 5 years | +93% | +8.6M shares |
| Available history | +94% | +8.7M shares |
BSEM has 18M diluted shares, down 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $1.00 |
BSEM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -1.5x | Net Cash |
| Q2 2025 | -1.2x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.6x | Net Cash |
| Q3 2024 | -0.5x | Net Cash |
| Q2 2024 | -0.2x | Net Cash |
| Q1 2024 | 19.3x | High |
BSEM has more cash than debt.
BSEM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.3 | Neutral |
| Stochastic | 3.2 | Oversold |
BSEM's weekly RSI is 32 (neutral) and its Stochastic is 3 (oversold).
BSEM PE vs Healthcare Sector
| Metric | BSEM | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
BSEM has no meaningful PE right now: it lost money over the past year.
BSEM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.07 | 37% below |
| 20 week MA | $3.08 | 58% below |
| 50 week MA | $4.09 | 68% below |
| 100 week MA | $7.27 | 82% below |
| 200 week MA | $6.91 | 81% below |
BSEM is in a downtrend: it's below all five of its weekly moving averages, and 81% below its 200-week average.
BSEM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.50 | $1.40 | -44% |
| 2021 | $1.40 | $1.10 | -21% |
| 2022 | $1.10 | $3.48 | +216% |
| 2023 | $3.48 | $5.86 | +68% |
| 2024 | $5.86 | $12.7 | +116% |
| 2025 | $12.7 | $3.87 | -69% |
| 2026 YTD | $3.87 | $1.30 | -66% |
BSEM's yearly returns have swung widely, from +216% in 2022 to −69% in 2025. It's down 66% so far in 2026.